Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC 4.0Melanoma Management

Open ilio-obturator lymphadenectomy for stage III cutaneous malignancies – a retrospective case series on cases with concurrent inguinal lymphadenectomy and a case report on the laparoscopic transperitoneal approach

  1. 1Department of Surgery, Zuyderland Medical Centre, Sittard-Geleen, the Netherlands
  2. 2GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands
  3. 3Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands

Abstract

Introduction: Ilio-obturator lymphadenectomy (IOL) is used in the treatment of stage III melanoma. IOL can be performed using a conventional open approach, minimally invasive transperitoneal or extraperitoneal approach. IOL is traditionally combined with inguinal lymphadenectomy (IL). From 2010–2024, open IOL (O-IOL) was standard in our hospital. The first laparoscopic transperitoneal IOL (LT-IOL) for stage III melanoma we performed in our hospital, had a detrimental outcome. This prompted us to review our complications after O-IOL. The aim of this study is to assess surgical complication rates and safety of O-IOL when combined with IL.

Methods: This was a single-center retrospective case series on O-IOL with concurrent IL. Primary outcome measures were complication rates and severity, readmissions and surgical reinterventions. Secondary outcome measures were technique for surgical approach, unplanned visits and oncological outcome.

Results: Between 2010 and 2024, 11 patients underwent O-IOL combined with IL. One patient (9.1%) developed a surgical site infection after O-IOL, which was treated with antibiotics and outpatient wound debridement. No other complications were observed. All patients developed complications related to concurrent IL.

Conclusions: O-IOL using a Rutherford-Morrison incision for the retroperitoneal approach shows low complication rates in this case series. In our described case, combining LT-IOL with IL resulted in a disastrous outcome.

Related

  1. Laparoscopic para-aortic and pelvic lymphadenectomy before chemoradiotherapy was not associated with improved survival in patients with FIGO stage IIB-IIIC cervical cancer: a single-center retrospective study.
    Qin Zhang, Lin Li, Xiuying Li +1
    Frontiers in oncologyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  2. Laparoscopic Transperitoneal Dismembered Pyeloplasty by Anderson-Hynes Procedure in Left Pelviureteric Junction Outlet Obstruction of a Horseshoe Kidney: A Case Report
    Aman Arora, Ishaan Shinde, Irshad A Khan +2
    CureusPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
  3. Safety analysis of the Weigao laparoscopic surgical robot for renal cyst decortication via transperitoneal and retroperitoneal approaches
    Run-Ze Pan, Hao Wang, Xin-Yu Liu +6
    Frontiers in SurgeryPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  4. Anti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies
    Maurice J Berkowitz, Karo K Arzoo
    CureusPeer-reviewedCC BY 4.0Full textOncologyPMC
  5. Dynamic serum chloride trajectories predict short- and long-term mortality in patients with malignancies: a retrospective cohort study with external validation
    Ruming Zhao, Shaojun Yang
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
BibTeX
@article{servaas2026open,
  title = {{Open ilio-obturator lymphadenectomy for stage III cutaneous malignancies – a retrospective case series on cases with concurrent inguinal lymphadenectomy and a case report on the laparoscopic transperitoneal approach}},
  author = {Nick Servaas and Emmy A. C. Maas and Loeki Aldenhoven and Merel A. Spiekerman van Weezelenburg and Eric H. J. Belgers and Elisabeth R. M. van Haaren and Alfred Janssen and Berry Meesters and Yvonne L. J. Vissers and Geerard L. Beets and James van Bastelaar},
  journal = {Melanoma Management},
  year = {2026},
  month = nov,
  doi = {10.1080/20450885.2026.2749737},
  url = {https://doi.org/10.1080/20450885.2026.2749737},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Open ilio-obturator lymphadenectomy for stage III cutaneous malignancies – a retrospective case series on cases with concurrent inguinal lymphadenectomy and a case report on the laparoscopic transperitoneal approach
AU  - Nick Servaas
AU  - Emmy A. C. Maas
AU  - Loeki Aldenhoven
AU  - Merel A. Spiekerman van Weezelenburg
AU  - Eric H. J. Belgers
AU  - Elisabeth R. M. van Haaren
AU  - Alfred Janssen
AU  - Berry Meesters
AU  - Yvonne L. J. Vissers
AU  - Geerard L. Beets
AU  - James van Bastelaar
PY  - 2026
DA  - 2026/11/06
JO  - Melanoma Management
DO  - 10.1080/20450885.2026.2749737
UR  - https://doi.org/10.1080/20450885.2026.2749737
AB  - Introduction: Ilio-obturator lymphadenectomy (IOL) is used in the treatment of stage III melanoma. IOL can be performed using a conventional open approach, minimally invasive transperitoneal or extraperitoneal approach. IOL is traditionally combined with inguinal lymphadenectomy (IL). From 2010–2024, open IOL (O-IOL) was standard in our hospital. The first laparoscopic transperitoneal IOL (LT-IOL) for stage III melanoma we performed in our hospital, had a detrimental outcome. This prompted us to review our complications after O-IOL. The aim of this study is to assess surgical complication rates and safety of O-IOL when combined with IL.  Methods: This was a single-center retrospective case series on O-IOL with concurrent IL. Primary outcome measures were complication rates and severity, readmissions and surgical reinterventions. Secondary outcome measures were technique for surgical approach, unplanned visits and oncological outcome.  Results: Between 2010 and 2024, 11 patients underwent O-IOL combined with IL. One patient (9.1%) developed a surgical site infection after O-IOL, which was treated with antibiotics and outpatient wound debridement. No other complications were observed. All patients developed complications related to concurrent IL.  Conclusions: O-IOL using a Rutherford-Morrison incision for the retroperitoneal approach shows low complication rates in this case series. In our described case, combining LT-IOL with IL resulted in a disastrous outcome.
SN  - 2045-0885
SN  - 2045-0893
ER  -